Bio-Communications Research Institute consists of a small but dedicated and talented group of research scientists who are passionate about discovering new solutions for better health. As a leader in biomedical science, our research accomplishments challenge the medical community to look at other options rather than just at pharmaceuticals for answers.
As a division of The Center for the Improvement of Human Functioning International, Inc., founded by Dr. Hugh Riordan and under the current direction of Dr. Neil Riordan (Director of Research), we continue to focus on cutting- edge research ranging from Cancer Research, Intravenous Vitamin C (IVC) Therapy, Vitamin and Nutrient Deficiencies, Subtle Energies, and Psychoacoustics to the emerging field of Adult Stem Cell Research.
Over the years our research has played a key role in forming the scientific basis for
Orthomolecular Medicine that describes the practice of preventing and treating disease by providing the body with optimal amounts of substances which are natural to the body. Orthomolecular practitioners and research scientists around the world look to BCRI as a leader in biomedical research among the scientific community. Most recently, we have been able to demonstrate that the lack of a single nutrient can enormously impact gene expression. This, along with many of our other findings, should increase public understanding of how important proper nutrition is for maintaining health and preventing degenerative diseases.
Our antigen research leads us to believe that plant material, which simulates the profile of tumor antigens, has profound anti-cancer properties. This is an outgrowth of our 11 year RECNAC cancer
Introduction : Hugh Riordan M.D., Founder
research, the goal of which was to find ways to eliminate cancer cells while not harming normal cells. That research generated patents which resulted in new products being made available. RECNAC II is now being supported with colleagues in Puerto Rico, where we are studying the impact of vitamin C on the immune system.
Our BCRI leadership, in understanding the mechanisms and usefulness of high-dose intravenous vitamin C, is being recognized worldwide. A recent paper by the
National Institutes of Health acknowledges that intravenous administration is more effective in raising plasma C levels than taking vitamin C orally. As a result of our preeminence in the use of high-dose vitamin C, physicians from the United States and many foreign countries come here to learn the protocol for administering IVC therapy and related lab procedures.
BCRI is also a leader in the less understood fields of subtle energies and psychoacoustics and is studying the effects of such energies on biological systems, including brain waves. BCRI is also assessing the mechanisms of interaction from magnetic fields and sound on cell growth and function.
Under the direction of Dr. Neil Riordan, Director of Research, current research initiatives also focus on Adult Stem Cell studies and the potential for converting adult stem cells into potent anti-tumor cells, as well as studying the effects of nutrients on adult stem cells. In this research, we do not and will not use embryonic stem cells as research has shown that placental stem cells or “adult stem cells” are better suited for therapeutic means because they come as the result of a normal infant being born. This naturally eliminates the genetic and congenital defective factors.
Results of our research are presented to the general and scientific community
through lectures, given locally and around the world, the
Health Hunter Newsletter, various peer-reviewed journals, and this website. BCRI operates totally independently of special interest pressures. BCRI neither solicits nor accepts tax-derived funds. All of our research funding comes from private donations from individuals, corporations, and foundations.
